Tasimelteon

Overview

Tasimelteon is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2103822).

API suppliers (3)

Suppliers of Tasimelteon backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Apotex Inc.Canada1 active DMF
• MAHIMA LIFE SCIENCES PRIVATE LTDIndia1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (5 approved US products), the latest listed US patent on Tasimelteon expires 21 Feb 2041 and exclusivity 1 Dec 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

N-[[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamide

Canonical SMILES

CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2

InChIKey

PTOIAAWZLUQTIO-GXFFZTMASA-N